Cambridge Investment Research Advisors’s MDxHealth MDXH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Hold	10,000	–	–	﹤0.01%	3770
2026 Q1	$23K	Hold	10,000	–	–	﹤0.01%	3888
2025 Q4	$36K	Buy	+10,000	New	+$39.5K	﹤0.01%	3770

Other funds holding MDXH

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

ISWM

Intesa Sanpaolo Wealth Management Ville De Luxembourg $500M AUM

Monetary Solutions Dayton, Ohio $116M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Cambridge Investment Research Advisors's MDXH Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its MDxHealth (MDXH) position steady in Q2 2026 at 10,000 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Cambridge Investment Research Advisors first reported a position in MDXH in Q4 2025 and has held it in 3 quarters since. The position peaked at $36K in Q4 2025. 6 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

Cambridge Investment Research Advisors held 10,000 shares of MDxHealth worth $4K as of Q2 2026.
Cambridge Investment Research Advisors left its MDxHealth share count unchanged in Q2 2026.
MDxHealth made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3770 holding.
Cambridge Investment Research Advisors first reported a position in MDxHealth in Q4 2025 and has held it in 3 quarters since.
Cambridge Investment Research Advisors's MDxHealth position peaked at $36K in Q4 2025.
6 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.